Anzeige
Mehr »
Login
Dienstag, 18.01.2022 Börsentäglich über 12.000 News von 667 internationalen Medien
Breaking News! Innocan Pharma - LPD-Humanversuche im Visier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PS0P ISIN: US92764N1028 Ticker-Symbol:  
NASDAQ
14.01.22
22:00 Uhr
38,700 US-Dollar
+1,050
+2,79 %
1-Jahres-Chart
VIR BIOTECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
VIR BIOTECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur VIR BIOTECHNOLOGY Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoVir Biotechnology and Bill & Melinda Gates Foundation to develop vaccinal antibody tech for tackling HIV and malaria5
FrVir expands partnership with Gates Foundation, adding $50M for HIV and malaria antibody research initiative1
FrGlaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US8
VIR BIOTECHNOLOGY Aktie jetzt für 0€ handeln
FrVir Biotech launches new research programme for HIV and malaria prevention3
FrEli Lilly and GlaxoSmithKline/Vir COVID-19 therapies get WHO backing15
DoVir Biotechnology, Gates Foundation expand partnership for treating HIV, malaria5
DoGlaxoSmithKline, Vir seek FDA nod for intramuscular use of COVID-19 therapy6
DoGSK, Vir seek US approval for COVID-19 antibody therapy as shot in arm9
DoVir Biotechnology Expands Partnership With Bill & Melinda Gates Foundation, Launches New Antibody Research Initiative Aimed At A Functional Cure For HIV And Prevention Of Malaria; Foundation Has Committed $40M Equity Investment And $10M Grant3
DoVir Biotechnology, Inc.: GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early ...3
DoVir Biotechnology, Inc.: Vir Biotechnology Launches New Antibody Research Initiative Aimed at a Functional Cure for HIV and Prevention of Malaria2
MiVir extends gains as Needham lifts sales outlook for COVID-19 antibody therapy9
MiGlaxo (GSK) & Vir to Supply More COVID Antibody Doses in US11
11.01.GlaxoSmithKline, Vir Say U.S. to Buy 600,000 More Covid Doses19
11.01.GSK, Vir To Supply Additional 60k Doses Of Sotrovimab To US Govt. For Early Treatment Of Covid-19280LONDON (dpa-AFX) - Pharma major GlaxoSmithKline Plc (GSK) and Vir Biotechnology, Inc. (VIR), on Tuesday said the U.S. Government will purchase an additional 0.6 million doses of Sotrovimab,...
► Artikel lesen
11.01.Vir Biotechnology jumps 8% on purchase agreement of Sotrovimab by the US government6
11.01.MFGP, LAC and VIR among pre market gainers9
11.01.Vir Biotechnology, Inc.: GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized ...9
04.01.Vir Biotechnology, Inc.: Vir Biotechnology to Present at 40th Annual J.P. Morgan Healthcare Conference17
31.12.21Vir Biotechnology, Inc.: Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron Immune Evasion and Receptor Engagement15
Seite:  Weiter >>
139 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,2,3